Novartis India has completed the transaction for the transfer of its Animal Health Division to Elanco India on December 31, 2015. This is pursuant to the approval received from the Foreign Investment Promotion Board, Government of India and the Competition Commission of India.
The company had earlier entered into transaction for transfer of its Animal Health Division as a going concern by way of a slump sale to Elanco India, or another affiliate of Eli Lilly and Company.
Novartis is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.
| Company Name | CMP |
|---|---|
| Redington | 222.80 |
| Adani Enterprises | 2505.65 |
| Amrapali Industries | 18.21 |
| Rashi Peripheral | 530.50 |
| PDS | 300.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: